vs
Side-by-side financial comparison of Clarus Corp (CLAR) and Phathom Pharmaceuticals, Inc. (PHAT). Click either name above to swap in a different company.
Clarus Corp is the larger business by last-quarter revenue ($65.4M vs $57.6M, roughly 1.1× Phathom Pharmaceuticals, Inc.). On growth, Phathom Pharmaceuticals, Inc. posted the faster year-over-year revenue change (94.1% vs -8.4%). Clarus Corp produced more free cash flow last quarter ($11.6M vs $-167.0M).
Clarus Corp is a global designer, manufacturer, and distributor of high-performance outdoor recreation, climbing, camping, and lifestyle products. It manages a portfolio of leading consumer brands, serving outdoor enthusiasts, professional athletes, and retail partners across North America, Europe, and the Asia-Pacific region, with a focus on innovative, durable gear for active lifestyles.
Phathom Pharmaceuticals is a clinical-stage biopharmaceutical firm focused on developing and commercializing innovative therapies for gastrointestinal diseases. Its lead product candidates address acid-related disorders, inflammatory bowel disease, and other GI conditions, serving patients mainly across North America and Europe.
CLAR vs PHAT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $65.4M | $57.6M |
| Net Profit | $-31.3M | — |
| Gross Margin | 27.7% | 86.7% |
| Operating Margin | -59.6% | — |
| Net Margin | -47.8% | — |
| Revenue YoY | -8.4% | 94.1% |
| Net Profit YoY | 52.3% | 71.6% |
| EPS (diluted) | $-0.81 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $65.4M | $57.6M | ||
| Q3 25 | $69.3M | $49.5M | ||
| Q2 25 | $55.2M | $39.5M | ||
| Q1 25 | $60.4M | $28.5M | ||
| Q4 24 | $71.4M | $29.7M | ||
| Q3 24 | $67.1M | $16.4M | ||
| Q2 24 | $56.5M | $7.3M | ||
| Q1 24 | $69.3M | — |
| Q4 25 | $-31.3M | — | ||
| Q3 25 | $-1.6M | $-30.0M | ||
| Q2 25 | $-8.4M | $-75.8M | ||
| Q1 25 | $-5.2M | $-94.3M | ||
| Q4 24 | $-65.5M | — | ||
| Q3 24 | $-3.2M | $-85.6M | ||
| Q2 24 | $-5.5M | $-91.4M | ||
| Q1 24 | $21.9M | — |
| Q4 25 | 27.7% | 86.7% | ||
| Q3 25 | 35.1% | 87.5% | ||
| Q2 25 | 35.6% | 87.2% | ||
| Q1 25 | 34.4% | 86.9% | ||
| Q4 24 | 33.4% | 87.1% | ||
| Q3 24 | 35.0% | 85.6% | ||
| Q2 24 | 36.1% | 81.2% | ||
| Q1 24 | 35.9% | — |
| Q4 25 | -59.6% | — | ||
| Q3 25 | -4.4% | -30.8% | ||
| Q2 25 | -19.7% | -151.7% | ||
| Q1 25 | -11.2% | -276.5% | ||
| Q4 24 | -70.2% | — | ||
| Q3 24 | -8.0% | -433.0% | ||
| Q2 24 | -14.4% | -1055.4% | ||
| Q1 24 | -9.8% | — |
| Q4 25 | -47.8% | — | ||
| Q3 25 | -2.3% | -60.5% | ||
| Q2 25 | -15.3% | -191.9% | ||
| Q1 25 | -8.7% | -330.7% | ||
| Q4 24 | -91.8% | — | ||
| Q3 24 | -4.7% | -523.3% | ||
| Q2 24 | -9.7% | -1248.6% | ||
| Q1 24 | 31.6% | — |
| Q4 25 | $-0.81 | — | ||
| Q3 25 | $-0.04 | $-0.41 | ||
| Q2 25 | $-0.22 | $-1.05 | ||
| Q1 25 | $-0.14 | $-1.31 | ||
| Q4 24 | $-1.72 | — | ||
| Q3 24 | $-0.08 | $-1.32 | ||
| Q2 24 | $-0.14 | $-1.56 | ||
| Q1 24 | $0.57 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $36.7M | $130.0M |
| Total DebtLower is stronger | $0 | $209.1M |
| Stockholders' EquityBook value | $196.4M | $-438.2M |
| Total Assets | $249.0M | $259.1M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $36.7M | $130.0M | ||
| Q3 25 | $29.5M | $135.2M | ||
| Q2 25 | $28.5M | $149.6M | ||
| Q1 25 | $41.3M | $212.3M | ||
| Q4 24 | $45.4M | $297.3M | ||
| Q3 24 | $36.4M | $334.7M | ||
| Q2 24 | $46.2M | $276.2M | ||
| Q1 24 | $47.5M | — |
| Q4 25 | $0 | $209.1M | ||
| Q3 25 | $2.0M | $207.1M | ||
| Q2 25 | $1.9M | $205.1M | ||
| Q1 25 | $1.9M | $203.2M | ||
| Q4 24 | $1.9M | $201.4M | ||
| Q3 24 | — | $175.7M | ||
| Q2 24 | — | $174.4M | ||
| Q1 24 | $37.0K | — |
| Q4 25 | $196.4M | $-438.2M | ||
| Q3 25 | $225.8M | $-422.5M | ||
| Q2 25 | $225.1M | $-405.8M | ||
| Q1 25 | $229.3M | $-338.4M | ||
| Q4 24 | $233.1M | $-253.6M | ||
| Q3 24 | $308.5M | $-187.1M | ||
| Q2 24 | $307.3M | $-233.8M | ||
| Q1 24 | $310.4M | — |
| Q4 25 | $249.0M | $259.1M | ||
| Q3 25 | $283.1M | $240.3M | ||
| Q2 25 | $286.5M | $250.2M | ||
| Q1 25 | $292.8M | $294.2M | ||
| Q4 24 | $294.1M | $378.3M | ||
| Q3 24 | $375.3M | $387.0M | ||
| Q2 24 | $369.4M | $319.4M | ||
| Q1 24 | $377.0M | — |
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.01× | — | ||
| Q2 25 | 0.01× | — | ||
| Q1 25 | 0.01× | — | ||
| Q4 24 | 0.01× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.00× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $12.5M | $-166.8M |
| Free Cash FlowOCF − Capex | $11.6M | $-167.0M |
| FCF MarginFCF / Revenue | 17.7% | -290.0% |
| Capex IntensityCapex / Revenue | 1.4% | 0.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-9.9M | $-328.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $12.5M | $-166.8M | ||
| Q3 25 | $-5.7M | $-14.1M | ||
| Q2 25 | $-9.4M | $-62.7M | ||
| Q1 25 | $-2.1M | $-84.9M | ||
| Q4 24 | $16.6M | $-266.8M | ||
| Q3 24 | $-8.3M | $-63.6M | ||
| Q2 24 | $834.0K | $-70.7M | ||
| Q1 24 | $-16.4M | — |
| Q4 25 | $11.6M | $-167.0M | ||
| Q3 25 | $-7.0M | $-14.1M | ||
| Q2 25 | $-11.3M | $-62.8M | ||
| Q1 25 | $-3.3M | $-84.9M | ||
| Q4 24 | $14.4M | $-266.9M | ||
| Q3 24 | $-9.4M | $-63.6M | ||
| Q2 24 | $-744.0K | $-70.8M | ||
| Q1 24 | $-18.3M | — |
| Q4 25 | 17.7% | -290.0% | ||
| Q3 25 | -10.0% | -28.6% | ||
| Q2 25 | -20.4% | -159.0% | ||
| Q1 25 | -5.4% | -297.9% | ||
| Q4 24 | 20.1% | -899.8% | ||
| Q3 24 | -14.0% | -389.0% | ||
| Q2 24 | -1.3% | -966.2% | ||
| Q1 24 | -26.3% | — |
| Q4 25 | 1.4% | 0.4% | ||
| Q3 25 | 1.8% | 0.1% | ||
| Q2 25 | 3.4% | 0.2% | ||
| Q1 25 | 2.0% | 0.1% | ||
| Q4 24 | 3.1% | 0.5% | ||
| Q3 24 | 1.6% | 0.3% | ||
| Q2 24 | 2.8% | 0.6% | ||
| Q1 24 | 2.7% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.75× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CLAR
| Other | $37.1M | 57% |
| Outdoor Segment | $25.3M | 39% |
| Adventure Segment | $3.0M | 5% |
PHAT
Segment breakdown not available.
